Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients.

about

Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients.

Item

http://www.wikidata.org/entity/Q55058359

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Cirrhosis is not a contraindic ...... y in highly selected patients.

@en

Cirrhosis is not a contraindic ...... y in highly selected patients.

@nl

type

Item

label

Cirrhosis is not a contraindic ...... y in highly selected patients.

@en

Cirrhosis is not a contraindic ...... y in highly selected patients.

@nl

prefLabel

Cirrhosis is not a contraindic ...... y in highly selected patients.

@en

Cirrhosis is not a contraindic ...... y in highly selected patients.

@nl

P1476

Cirrhosis is not a contraindic ...... y in highly selected patients.

@en

P2093

Andrew M Lowy

http://www.w3.org/2001/XMLSchema#string

Anna Weiss

http://www.w3.org/2001/XMLSchema#string

Erin P Ward

http://www.w3.org/2001/XMLSchema#string

Joel M Baumgartner

http://www.w3.org/2001/XMLSchema#string

Kaitlyn J Kelly

http://www.w3.org/2001/XMLSchema#string

P2860

A new standard of care for the management of peritoneal surface malignancy

Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies.

Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis.

Pharmacokinetics of intraperitoneal cisplatin and doxorubicin.

Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patients

Comprehensive management of diffuse malignant peritoneal mesothelioma.

Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma.

A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.

P2888

s12957-018-1389-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12957-018-1389-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103657221

http://www.w3.org/2001/XMLSchema#string

P698

29699564

http://www.w3.org/2001/XMLSchema#string

P932

5922306

http://www.w3.org/2001/XMLSchema#string